LoginSignup
Certara logo

Certara

Stock
Stock
ISIN: US15687V1098
Ticker: CERT
US15687V1098
CERT

Price

Price

Frequently asked questions

What is Certara's market capitalization?

The market capitalization of Certara is $1.57B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is the Earnings Per Share (EPS) for Certara?

Certara's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$0.194. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Certara's stock?

Currently, 11 analysts cover Certara's stock, with a consensus target price of $19.72. Analyst ratings provide insights into the stock's expected performance.

What is Certara's revenue over the trailing twelve months?

Over the trailing twelve months, Certara reported a revenue of $372.80M.

What is the EBITDA for Certara?

Certara's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $60.38M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Certara?

Certara has a free cash flow of $34.85M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of Certara's stock?

The 5-year beta for Certara is 1.48. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does Certara have, and what sector and industry does it belong to?

Certara employs approximately 1,338 people. It operates in the Information Technology sector, specifically within the Software & Programming industry.

What is the free float of Certara's shares?

The free float of Certara is 120.45M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 $1.57B

5Y beta

 1.48

EPS (TTM)

 -$0.194

Free Float

 120.45M

Revenue (TTM)

 $372.80M

EBITDA (TTM)

 $60.38M

Free Cashflow (TTM)

 $34.85M

Pricing

52W span
$9.41$19.87

Analyst Ratings

The price target is $19.72 and the stock is covered by 11 analysts.

Buy

4

Hold

7

Sell

0

Information

Certara, Inc. is engaged in model-informed drug development. The Company accelerates medicine using biosimulation software, technology and services to transform traditional drug discovery and development. It delivers software products and technology-driven services to customers to efficiently carry out and realize the full benefits of biosimulation in drug discovery, preclinical and clinical research, regulatory submissions and market access. Its regulatory science and market access software and services are underpinned by technologies such as regulatory submissions software, natural language processing and Bayesian analytics. It also develops scientific informatics software products used by the life sciences industry for in-silico research. It develops advanced modeling and biosimulation solutions used to predict the pharmacokinetic and pharmacodynamic properties. Its clients include 2,400 biopharmaceutical companies, academic institutions and regulatory agencies across 66 countries.

1,338

Software & Programming

Information Technology

Identifier

ISIN

US15687V1098

Primary Ticker

CERT

Knockouts

Join the conversation
Sign upLogin